Skip to main content
letter
. 2013 Oct 24;109(12):3127–3129. doi: 10.1038/bjc.2013.651

Table 1. Frequency of ILN in liver metastases from colorectal cancer according to treatment.

  No treatment, N=29 CT only, N=31 CT+Beva, N=31 P-valuea
Presence of ILN
0 (0%)
12 (39%)
21 (68%)
P<0.001
Lack of ILN 29 (100%) 19 (61%) 10 (32%)  

Abbreviations: Beva=bevacizumab; CT=chemotherapy; ILN=infract-like necrosis.

a

χ2-test.